SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-008266
Filing Date
2022-04-05
Accepted
2022-04-05 06:04:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dmtp20220329_defa14a.htm DEFA14A 7929
2 d01.jpg GRAPHIC 232087
3 d02.jpg GRAPHIC 170031
  Complete submission text file 0001437749-22-008266.txt   562817
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36291 | Film No.: 22805110
SIC: 2834 Pharmaceutical Preparations